DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer

Journal of the National Cancer Institute

Volumn 97, Issue 2, 2005, Pages 127-132

  Kennedy, David O ^a   Agrawal, Meenakshi ^a   Shen, Jing ^a   Terry, Mary Beth ^b   Zhang, Fang Fang ^b   Senie, Ruby T ^b   Motykiewicz, Grazyna ^a   Santella, Regina M ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROXYBENZO[A]PYRENE OXIDE; DNA ANTIBODY; POLYCLONAL ANTIBODY; BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; CARCINOGEN; DNA; MUTAGENIC AGENT;

ADULT; AGE; ARTICLE; BLOOD DONOR; BODY MASS; BREAST CANCER; CALCULATION; CANCER FAMILY; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CELL CULTURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CULTURE MEDIUM; DNA ADDUCT; EXCISION REPAIR; FAMILY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LOGISTIC REGRESSION ANALYSIS; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SIBLING; SMOKING; STAINING; STATISTICAL MODEL; TIME; ANALYSIS OF VARIANCE; BREAST TUMOR; CASE CONTROL STUDY; DNA DAMAGE; DNA REPAIR; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC PREDISPOSITION; GENETICS; LYMPHOCYTE; METABOLISM; RISK;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOGENS; CASE-CONTROL STUDIES; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; LYMPHOCYTES; MUTAGENS; ODDS RATIO; SIBLINGS;

EID: 13744250657     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/dji013     Document Type: Article

References (22)

1. Berwick M, Vineis, P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000:92:874-97.
2. Benhamou S, Sarasin, A. Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 2000;462:149-58.
3. Smith TR, Miller MS, Lohman KK, Case LD, Hu JJ. DNA damage and breast cancer risk. Carcinogenesis 2003;24:883-9.
4. Rajeswari N, Ahuja YR, Malini U, Chandrashekar S, Balakrishna N, Rao KV, et al. Risk assessment in first degree female relatives of breast cancer patients using the alkaline Comet assay. Carcinogenesis 2000;21:557-61.
5. Xiong P, Bondy ML, Li D, Shen H, Wang LE, Singletary SE, et al. Sensitivity to benzo(a)pyrene diol-epoxide associated with risk of breast cancer in young women and modulation by glutathione S-transferase polymorphisms: a case-control study. Cancer Res 2001;61:8465-9.
6. Roy SK, Trivedi AH, Bakshi SR, Patel SJ, Shukla PH, Bhatavdekar JM, et al. Bleomycin-induced chromosome damage in lymphocytes indicates inefficient DNA repair capacity in breast cancer families. J Exp Clin Cancer Res 2000;19:169-73.
7. Ramos JM, Ruiz A, Colen R, Lopez ID, Grossman L, Matta, JL. DNA repair and breast carcinoma susceptibility in women. Cancer 2004;100: 1352-7.
8. Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, Wei Q. Reduced DNA repair of benzo(a)pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 2004:25: 1695-700.
9. Gammon MD, Santella RM, Neugut AI, Eng SM, Teitelbaum SL, Paykin A, et al. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev 2002;11:677-85.
10. Perera FP, Estabrook A, Hewer A, Channing K, Rundle A, Mooney LA, et al. (1995) Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 1995;4:233-8.
11. Motykiewicz G, Faraglia B, Wang L, Terry MB, Senie RT, Santella RM. Removal of benzo(a)pyrene diol epoxide (BPDE-DNA) adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer. Environ Mol Mutagen 2002;40:93-100.
12. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, et al. The Breast Cancer Family registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6:389.
13. Beck JC, Beiswanger CM, John EM, Satariano E West D. Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies. Cancer Epidemiol Biomarkers Prev 2001;10:551-4.
14. Motykiewicz G, Malusecka E, Grzybowska E, Chorazy M, Zhang YJ, Perera FP, et al. Immunohistochemical quantitation of polycyclic aromatic hydrocarbon-DNA adducts in human lymphocytes. Cancer Res, 1995;55: 1417-22.
15. Mumford JL, Williams K, Wilcosky TC, Everson RB, Young TL, Santella RM. A sensitive color ELISA for detecting polycyclic aromatic hydrocarbon-DNA adducts in human tissues. Mutat Res 1996;359:171-7.
16. Hosmer DW, Lemenshow S. Applied logistic regression. New York (NY): John Wiley & Sons; 1989.
17. Moriwaki S, Ray S, Tarone RE, Kraemer KH, Grossman L. The effect of donor age on the processing of UV-damaged DNA by cultured human cells: reduced DNA repair capacity and increased DNA mutability. Mutat Res 1996;364:117-23.
18. Wei Q. Effect of aging on DNA repair and skin carcinogenesis: a mini-review of population-based studies. J Invest Dermatol Symp Proc 1998;3: 19-22.
19. D'Errico M, Calcagnile A, Iavarone I, Sera F, Baliva G, Chinni LM, et al. Factors that influence the DNA repair capacity of normal and skin cancer-affected individuals. Cancer Epidemiol Biomarkers Prev 1999; 8:553-9.
20. Wu X, Gu J, Hong WK, Lee JJ, Amos CI, Jiang H, et al. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst 1998;90:1393-9.
21. Athas WF, Hedayati MA, Matanoski GM, Farmer ER, Grossman L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res 1991;51:5786-93.
22. Wei Q, Spitz MR, Gu J, Cheng L, Xu X, Strom SS, et al. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol Biomarkers Prev 1996;5:199-204.